Revive's success with bucillamine will remove the need for patients with mild to moderate COVID-19 symptoms to be on ventilators, therefore allowing the ventilators to be utilized for critical life supporting needs. I'm with a lot of you here that suggested that Revive might get FDA fast-track status especially knowing the positive history of bucillamine.
August 15th. 2020
OTTAWA — Only a small fraction of the 40,000 new ventilators Canada ordered for hospitals last spring have already been delivered but several companies involved say their production lines will start delivering the products faster in the next few weeks.
The promise of new arrivals comes as Canada's chief public health officer, Dr. Theresa Tam, warned Friday that a fall surge of COVID-19 cases could overwhelm the health-care system, including its supply of critical care beds and ventilators.
"What we know based on what we learned from other countries and cities that had a devastating impact in that initial wave, if you exceeded that capacity the mortality goes up really, really high," she said.
Flu season and other respiratory infections common in the fall could put added pressure on the system if COVID-19 flares up in a big way.
Tam said there were many lessons learned from the spring, when the government was ill-prepared and without enough protective equipment for health-care workers, and feared a massive surge of COVID-19 would overwhelm the health-care system.
"We are much better prepared than we were before," she said.
In March, Canadians watched in horror as northern Italy's COVID-19 outbreak overran its health-care system, leaving doctors to choose which patients got a ventilator and which were left without one. That experience, coupled with warnings it could happen here too, compelled federal and provincial governments to order thousands of new ventilators.
